Adma Biologics Inc/ US0008991046 /
5/17/2024 10:00:00 PM | Chg. +0.1500 | Volume | Bid12:59:59 AM | Ask12:59:59 AM | High | Low |
---|---|---|---|---|---|---|
9.2100USD | +1.66% | 3.63 mill. Turnover: 29.88 mill. |
9.2000Bid Size: 100 | 9.3000Ask Size: 5,000 | 9.3100 | 8.9100 |
GlobeNewswire
5/9
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
3/11
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ ...
GlobeNewswire
3/5
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
GlobeNewswire
2/28
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business U...
GlobeNewswire
2/21
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
GlobeNewswire
12/18/2023
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Manage...
GlobeNewswire
12/12/2023
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Year...
GlobeNewswire
11/16/2023
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
GlobeNewswire
11/8/2023
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
11/1/2023
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
GlobeNewswire
3/25/2022
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 M...
GlobeNewswire
3/24/2022
ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business U...
GlobeNewswire
3/21/2022
ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
GlobeNewswire
3/7/2022
ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA
GlobeNewswire
1/19/2022
ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides ...
GlobeNewswire
1/18/2022
ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek...
GlobeNewswire
12/6/2021
First Wave BioPharma’s CEO and President, James Sapirstein, to Participate in CEO Panel Discussion a...
GlobeNewswire
11/17/2021
ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of...